|Marisa S. Bartolomei, PhD
Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine
Marisa S. Bartolomei received her BS in Biochemistry at the University of Maryland in 1982. She then obtained her PhD in 1987 in the Biochemistry, Cell & Molecular Biology program at the Johns Hopkins University School of Medicine. She trained as a postdoctoral fellow with Dr. Shirley Tilghman at Princeton University. In 1993, Dr. Bartolomei was appointed as an Assistant Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine and was promoted to Associate Professor with tenure in 1999 and Professor in 2006. She was also an investigator of the Howard Hughes Medical Institute for 10 years. In 2006, Dr. Bartolomei received the Society for Women's Health Research Medtronics Prize for Contributions to Women's Health.
|C. Anthony Blau, MD
Professor in the Division of Hematology, Department of Medicine and Adjunct Professor in the Department of Genome Sciences at the University of Washington
Tony Blau is a Professor in the Division of Hematology, Department of Medicine and Adjunct Professor in the Department of Genome Sciences at the University of Washington (UW). Originally from Ohio, Blau was drawn to Seattle because of its legacy as the birthplace of bone marrow transplantation, the first stem cell therapy.
|Martin M. Matzuk, MD, PhD
Stuart A. Wallace Chair and Professor of Pathology and Immunology at Baylor College of Medicine and Director of Clinical Chemistry at Ben Taub General Hospital
Martin M. Matzuk, M.D., Ph.D., is the Stuart A. Wallace Chair and Professor of Pathology and Immunology at Baylor College of Medicine and Director of Clinical Chemistry at Ben Taub General Hospital. He graduated from the University of Chicago with a B.A. with Honors in Biology, received his M.D. and Ph.D. from Washington University School of Medicine, and performed his residency training at the University of Pennsylvania and Baylor College of Medicine. He is a board-certified clinical pathologist, cancer biologist and reproductive biologist.
|Bryan Richardson, MD, FRCSC
Professor and Chair, Department of Obstetrics and Gynaecology
Professor, Departments of Physiology/Pharmacology and Pediatrics
Canada Research Chair, Tier 1 Fetal and Neonatal Health and Development
Schulich School of Medicine and Dentistry
University of Western Ontario, London, Ontario, Canada
Dr. Richardson received his medical degree from The University of Western Ontario and subsequent training in Obstetrics and Gynaecology. He then attended the University of Oregon Health Sciences Centre in Portland, Oregon for training in Maternal-Fetal Medicine and Perinatal Physiology. He is a member of numerous professional societies including the Society of Obstetricians & Gynaecologists of Canada, the Society for Gynecological Investigation, and the Perinatal Research Society where he has served on both the Executive Council and as the Past President. Dr. Richardson is a Reviewer for several scientific medical journals, is a Board Member and Editorial Consultant to the Journal Early Human Development and the journal Reproductive Sciences. He is a past Committee Member for the MRC Clinical Investigation Committee and was a member of the inaugural CIHR Advisory Board for the Institute of Human Development, Child and Youth Health.
Dr. Richardson has sat on numerous scientific panels and workshops and has been invited to give over 140 scientific presentations, with many of these at national and international meetings as further recognition of his research contributions. He has published 123 peer review medical articles, 18 book chapters and symposia, and 312 scientific abstracts. He has had long standing support from the Canadian Institutes of Health Research, initially as an MRC Fellow, and subsequently as a Scholar, with continuous grant support since 1983, most recently as a member of the CIHR Group in Fetal Growth Restriction: Mechanisms and Outcomes. He was the first Wyeth/CIHR Clinical Research Chair in Women's Health and Perinatology providing continued support for his clinical and basic research study relating to fetal behavioural activity and the relationship to brain development. He is presently a Canada Research Chair Tier 1 in Fetal and Neonatal Health and Development.
|Yoel Sadovsky, MD
Director, Magee-Womens Research Institute
Elsie Hilliard Hillman Chair of Women’s Health Research
Professor of OBGYN, Microbiology and Molecular Genetics, and Clinical and Translational Science
Department of OBGYN and Reproductive Sciences
University of Pittsburgh
Yoel Sadovsky received his MD degree from the Hebrew University-Hadassah Medical School in Jerusalem in 1986, followed by OBGYN residency at Washington University in St. Louis and maternal-fetal medicine and postdoctoral research fellowships at the University of California, San Francisco. He then returned to Washington University as a reproductive biologist and specialist in high-risk pregnancy, where he was appointed tenured professor of OBGYN, and Cell Biology and Physiology in 2004. Dr. Sadovsky served as director of the Maternal-Fetal Medicine Fellowship at Washington University between 1997-07, and as Director, Division of Maternal-Fetal Medicine and Ultrasound from 1999-2007. In 2007, he assumed Scientific Directorship of Magee-Womens Research Institute (MWRI) in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Pittsburgh. The Institute is home to 60 faculty members and another 40 affiliate members within the greater University of Pittsburgh community, all engaged in basic, translational and clinical research in the fields of reproductive biology, development, and women’s health.